Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Boston Scientific Corp (BSX)  
$73.69 0.41 (0.55%) as of 4:30 Fri 5/10


Download
   
Exchange: New York Stock Exchange
Security Type: Common
Shares Out: 1,430,000,000
Market Cap: 105.38(B)
Last Volume: 3,790,549 Avg Vol: 8,454,629
52 Week Range: $48.64 - $74.1
Level I Sector: Health Care
Level II Sector: Health Services
Level III Sector: Medical Instruments & Supplies

Member Indexes:
    S&P COMPOSITE 1500     NYSE COMPOSITE
    S&P 500

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  297
Guru Rank Value     : 4.1
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 125,097 292,774 846,826 1,890,829
Total Sell Value $8,578,386 $18,202,620 $47,460,549 $93,238,165
Total People Sold 7 8 10 13
Total Sell Transactions 13 22 39 73
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 1823
  Page 22 of 73  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Onuscheck John Michael SVP & President, EMEA   •       –      –    2012-02-16 4 D $5.97 $12,782 D/D (2,141) 50,897     -
   Onuscheck John Michael SVP & President, EMEA   •       –      –    2012-02-16 4 OE $0.00 $0 D/D 5,060 53,038     -
   Nanavaty Maulik SVP & Pres, Neuromodulation   •       –      –    2012-02-16 4 D $5.97 $3,875 D/D (649) 54,585     -
   Nanavaty Maulik SVP & Pres, Neuromodulation   •       –      –    2012-02-16 4 OE $0.00 $0 D/D 2,115 55,234     -
   Neumann Lawrence R SVP and Pres, Emerging Markets   •       –      –    2012-02-16 4 D $5.97 $10,603 D/D (1,776) 70,601     -
   Neumann Lawrence R SVP and Pres, Emerging Markets   •       –      –    2012-02-16 4 OE $0.00 $0 D/D 4,943 72,377     -
   Pierce David A SVP and President, Endoscopy   •       –      –    2012-02-16 4 D $5.97 $10,979 D/D (1,839) 6,371     -
   Pierce David A SVP and President, Endoscopy   •       –      –    2012-02-16 4 OE $0.00 $0 D/D 5,121 8,210     -
   Phalen Michael P. EVP & President, MedSurg   •       –      –    2012-02-16 4 D $5.97 $10,125 D/D (1,696) 49,081     -
   Phalen Michael P. EVP & President, MedSurg   •       –      –    2012-02-16 4 OE $0.00 $0 D/D 4,723 50,777     -
   Burns Brian R EVP - Global Quality & Reg Aff   •       –      –    2012-02-16 4 D $5.97 $14,292 D/D (2,394) 71,703     -
   Burns Brian R EVP - Global Quality & Reg Aff   •       –      –    2012-02-16 4 OE $0.00 $0 D/D 6,747 74,097     -
   Pratt Timothy A. EVP, GC & Chief Admin Officer   •       –      –    2012-02-16 4 D $5.97 $55,479 D/D (9,293) 72,581     -
   Pratt Timothy A. EVP, GC & Chief Admin Officer   •       –      –    2012-02-16 4 OE $0.00 $0 D/D 28,434 81,874     -
   Fitzgerald Joseph Michael SVP & President, CRM   •       –      –    2012-02-16 4 D $5.97 $10,406 D/D (1,743) 67,348     -
   Fitzgerald Joseph Michael SVP & President, CRM   •       –      –    2012-02-16 4 OE $0.00 $0 D/D 4,723 69,091     -
   Capello Jeffrey D EVP & Chief Financial Officer   •       –      –    2012-02-16 4 D $5.97 $40,118 D/D (6,720) 114,087     -
   Capello Jeffrey D EVP & Chief Financial Officer   •       –      –    2012-02-16 4 OE $0.00 $0 D/D 20,242 120,807     -
   Dawkins Keith D Sr. VP, Global Chief Med. Off.   •       –      –    2012-02-16 4 D $5.97 $7,230 D/D (1,211) 56,980     -
   Dawkins Keith D Sr. VP, Global Chief Med. Off.   •       –      –    2012-02-16 4 OE $0.00 $0 D/D 3,373 58,191     -
   Pierce David A SVP and President, Endoscopy   •       –      –    2012-02-13 4 D $5.94 $3,427 D/D (577) 3,089     -
   Pierce David A SVP and President, Endoscopy   •       –      –    2012-02-13 4 OE $0.00 $0 D/D 1,605 3,666     -
   Onuscheck John Michael SVP & President, EMEA   •       –      –    2012-02-13 4 D $5.94 $4,116 D/D (693) 47,978     -
   Onuscheck John Michael SVP & President, EMEA   •       –      –    2012-02-13 4 OE $0.00 $0 D/D 1,638 48,671     -
   Kucheman William Chief Executive Officer   •       •      –    2012-02-12 4 D $5.93 $7,774 D/D (1,311) 81,712     -
  1823 Records found
  Previous  20  21  22  23  24  25  26  27  28  29  Next   
  Page 22 of 73
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us